跳至主要内容
临床试验/CTRI/2021/12/038388
CTRI/2021/12/038388招募中未知

Efficacy of oral Sodium Chloride supplementation in reducing the incidence of Hyponatremia in children with epilepsy receiving Oxcarbazepine monotherapy:A Randomized Controlled Trial. - SCHO trial

All India Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Children aged 1-18 years
  • 2. Newly diagnosed with epilepsy (structural/non-structural)

排除标准

  • 1. Receiving any other ASM/other medications which interfere with
  • serum sodium and/or body water balance
  • 2. Chronic renal, gastrointestinal, hepatic, pulmonary, cardiac or
  • endocrinal illness
  • 3. IAP grade II or more PEM
  • 4. Baseline hyponatremia/hypernatremia
  • 5. Receiving intravenous fluid at the time of starting oxcarbazepine
  • 6. Anorexia/Bulimia nervosa
  • 7. Caregiver not providing informed consent

研究者

相似试验

Sodium Chloride supplementation in reducing... | 临床试验